Management of young women with early breast cancer

Francesca Poggio; Matteo Lambertini; Claudia Bighin; BENEDETTA CONTE; Eva Blondeaux; Alessia D'Alonzo; Chiara Dellepiane; Francesco Boccardo; Lucia Del Mastro

doi:10.1136/esmoopen-2018-000458

Management of young women with early breast cancer

Francesca Poggio, Matteo Lambertini, Claudia Bighin, BENEDETTA CONTE, Eva Blondeaux, Alessia D'Alonzo, Chiara Dellepiane, Francesco Boccardo, Lucia Del Mastro

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Breast cancer is still the most frequent cancer diagnosed in women aged ≤40 years and the primary cause of death in this age group. The management of these patients needs a dedicated approach involving a multidisciplinary team that takes into account their treatment and survivorship issues. The present review aims to provide a perspective on the many challenges associated with treatment of young women with early breast cancer. We will focus on the standard (neo)adjuvant treatment, highlighting the paucity of age-specific results about the available genomic signatures, the groundbreaking landscape of adjuvant endocrine therapy and the relevant issue of the fertility preservation.

Lingua originale	Inglese
pagine (da-a)	e000458-1-e000458-4
Numero di pagine	4
Rivista	ESMO Open
Volume	3
DOI	https://doi.org/10.1136/esmoopen-2018-000458
Stato di pubblicazione	Pubblicato - 2018

Keywords

adjuvant treatments
breast cancer
fertility
premenopausal
young women

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1136/esmoopen-2018-000458

https://hdl.handle.net/11579/192906

Altri file e collegamenti

handle

Cita questo

@article{4082d7348af84d84b871202fd6dba375,

title = "Management of young women with early breast cancer",

abstract = "Breast cancer is still the most frequent cancer diagnosed in women aged ≤40 years and the primary cause of death in this age group. The management of these patients needs a dedicated approach involving a multidisciplinary team that takes into account their treatment and survivorship issues. The present review aims to provide a perspective on the many challenges associated with treatment of young women with early breast cancer. We will focus on the standard (neo)adjuvant treatment, highlighting the paucity of age-specific results about the available genomic signatures, the groundbreaking landscape of adjuvant endocrine therapy and the relevant issue of the fertility preservation.",

keywords = "adjuvant treatments, breast cancer, fertility, premenopausal, young women, adjuvant treatments, breast cancer, fertility, premenopausal, young women",

author = "Francesca Poggio and Matteo Lambertini and Claudia Bighin and BENEDETTA CONTE and Eva Blondeaux and Alessia D'Alonzo and Chiara Dellepiane and Francesco Boccardo and {Del Mastro}, Lucia",

year = "2018",

doi = "10.1136/esmoopen-2018-000458",

language = "English",

volume = "3",

pages = "e000458--1--e000458--4",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Management of young women with early breast cancer

AU - Poggio, Francesca

AU - Lambertini, Matteo

AU - Bighin, Claudia

AU - CONTE, BENEDETTA

AU - Blondeaux, Eva

AU - D'Alonzo, Alessia

AU - Dellepiane, Chiara

AU - Boccardo, Francesco

AU - Del Mastro, Lucia

PY - 2018

Y1 - 2018

N2 - Breast cancer is still the most frequent cancer diagnosed in women aged ≤40 years and the primary cause of death in this age group. The management of these patients needs a dedicated approach involving a multidisciplinary team that takes into account their treatment and survivorship issues. The present review aims to provide a perspective on the many challenges associated with treatment of young women with early breast cancer. We will focus on the standard (neo)adjuvant treatment, highlighting the paucity of age-specific results about the available genomic signatures, the groundbreaking landscape of adjuvant endocrine therapy and the relevant issue of the fertility preservation.

AB - Breast cancer is still the most frequent cancer diagnosed in women aged ≤40 years and the primary cause of death in this age group. The management of these patients needs a dedicated approach involving a multidisciplinary team that takes into account their treatment and survivorship issues. The present review aims to provide a perspective on the many challenges associated with treatment of young women with early breast cancer. We will focus on the standard (neo)adjuvant treatment, highlighting the paucity of age-specific results about the available genomic signatures, the groundbreaking landscape of adjuvant endocrine therapy and the relevant issue of the fertility preservation.

KW - adjuvant treatments

KW - breast cancer

KW - fertility

KW - premenopausal

KW - young women

KW - adjuvant treatments

KW - breast cancer

KW - fertility

KW - premenopausal

KW - young women

UR - https://iris.uniupo.it/handle/11579/192906

U2 - 10.1136/esmoopen-2018-000458

DO - 10.1136/esmoopen-2018-000458

M3 - Article

SN - 2059-7029

VL - 3

SP - e000458-1-e000458-4

JO - ESMO Open

JF - ESMO Open

ER -

Management of young women with early breast cancer

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo